Bayer Aktiengesellscha (Germany) Today
| BAYA Stock | EUR 4.80 0.14 2.83% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Bayer Aktiengesellscha is trading at 4.80 as of the 27th of November 2024. This is a 2.83 percent down since the beginning of the trading day. The stock's lowest day price was 4.8. Bayer Aktiengesellscha has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Bayer Aktiengesellschaft are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of December 2022 and ending today, the 27th of November 2024. Click here to learn more.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER ADR is traded on Frankfurt Stock Exchange in Germany. The company has 3.93 B outstanding shares. More on Bayer Aktiengesellschaft
Moving together with Bayer Stock
Moving against Bayer Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bayer Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bayer Aktiengesellscha's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bayer Aktiengesellscha or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Bayer Aktiengesellschaft (BAYA) is traded on Frankfurt Exchange in Germany and employs 102,296 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 55.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bayer Aktiengesellscha's market, we take the total number of its shares issued and multiply it by Bayer Aktiengesellscha's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bayer Aktiengesellschaft operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 3.93 B outstanding shares.
Bayer Aktiengesellschaft has accumulated about 8.19 B in cash with 5.09 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.09.
Check Bayer Aktiengesellscha Probability Of Bankruptcy
Ownership AllocationBayer Aktiengesellscha holds a total of 3.93 Billion outstanding shares. Almost 99.9 percent of Bayer Aktiengesellscha outstanding shares are held by general public with 0.1 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bayer Ownership Details
Bayer Aktiengesellschaft Risk Profiles
Although Bayer Aktiengesellscha's alpha and beta are two of the key measurements used to evaluate Bayer Aktiengesellscha's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.16 | |||
| Standard Deviation | 4.06 | |||
| Variance | 16.51 | |||
| Risk Adjusted Performance | (0.08) |
Bayer Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bayer Aktiengesellscha without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Bayer Aktiengesellscha Corporate Management
Elected by the shareholders, the Bayer Aktiengesellscha's board of directors comprises two types of representatives: Bayer Aktiengesellscha inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bayer. The board's role is to monitor Bayer Aktiengesellscha's management team and ensure that shareholders' interests are well served. Bayer Aktiengesellscha's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bayer Aktiengesellscha's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sarena Lin | Labor Officer | Profile | |
| Oliver Maier | Head Relations | Profile | |
| Gabriel Harnier | Patents Law | Profile | |
| Heiko Schipper | Member Division | Profile | |
| Rodrigo Santos | Member Division | Profile | |
| Michael Preuss | Gov Communications | Profile | |
| Stefan Oelrich | Head Management | Profile |
Other Information on Investing in Bayer Stock
Bayer Aktiengesellscha financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer Aktiengesellscha security.